Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1/2 trial of LB-001

Trial Profile

Phase 1/2 trial of LB-001

Status: Planning
Phase of Trial: Phase I/II

Latest Information Update: 10 Jan 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs LB 001 (Primary)
  • Indications Methylmalonic acidaemia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors LogicBio Therapeutics
  • Most Recent Events

    • 10 Jan 2020 According to a LogicBio Therapeutics media release, company has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to initiate this study.
    • 13 Aug 2019 According to an LogicBio Therapeutics media release, this trial is expected to begin in 1H 2020 and preliminary data is anticipated in 2H 2020.
    • 13 Aug 2019 According to an LogicBio Therapeutics media release, the company plans to file an Investigational New Drug application for LB-001 in the fourth quarter of 2019 and the details regarding clinical trial size, endpoints and timelines to be communicated upon IND acceptance.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top